Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 3
1995 3
1997 3
1998 2
1999 4
2000 1
2001 4
2002 3
2003 1
2004 2
2005 1
2006 2
2007 1
2008 1
2009 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
Hereditary 1,25-Dihydroxyvitamin D-resistant rickets.
Malloy PJ, Feldman D. Malloy PJ, et al. Endocr Dev. 2003;6:175-99. doi: 10.1159/000072776. Endocr Dev. 2003. PMID: 12964432 Review. No abstract available.
Vitamin D and prostate cancer.
Feldman D, Skowronski RJ, Peehl DM. Feldman D, et al. Adv Exp Med Biol. 1995;375:53-63. doi: 10.1007/978-1-4899-0949-7_5. Adv Exp Med Biol. 1995. PMID: 7645428 Review.
Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.
Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D. Krishnan AV, et al. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):694-702. doi: 10.1016/j.jsbmb.2006.12.051. Epub 2007 Jan 16. J Steroid Biochem Mol Biol. 2007. PMID: 17229571
Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.
Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS Jr, Whittemore AS. Oakley-Girvan I, et al. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1325-30. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298953 Free article.
Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S, Krishnan AV, Moreno J, Bhattacharyya RS, Gardner C, Brooks JD, Peehl DM, Feldman D. Swami S, et al. Int J Cancer. 2009 May 1;124(9):2050-9. doi: 10.1002/ijc.24161. Int J Cancer. 2009. PMID: 19127598 Free PMC article. Clinical Trial.
A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.
Krishnan AV, Zhao XY, Swami S, Brive L, Peehl DM, Ely KR, Feldman D. Krishnan AV, et al. Endocrinology. 2002 May;143(5):1889-900. doi: 10.1210/endo.143.5.8778. Endocrinology. 2002. PMID: 11956172
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Husbeck B, Bhattacharyya RS, Feldman D, Knox SJ. Husbeck B, et al. Mol Cancer Ther. 2006 Aug;5(8):2078-85. doi: 10.1158/1535-7163.MCT-06-0056. Mol Cancer Ther. 2006. PMID: 16928829 Free article.
A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1 alpha,25-dihydroxyvitamin D(3).
Gardezi SA, Nguyen C, Malloy PJ, Posner GH, Feldman D, Peleg S. Gardezi SA, et al. J Biol Chem. 2001 Aug 3;276(31):29148-56. doi: 10.1074/jbc.M100898200. Epub 2001 May 21. J Biol Chem. 2001. PMID: 11369766 Free article.
35 results
Jump to page